Literature DB >> 20523046

The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease.

G Talarico1, P Piscopo, M Gasparini, E Salati, M Pignatelli, S Pietracupa, L Malvezzi-Campeggi, A Crestini, S Boschi, G L Lenzi, A Confaloni, G Bruno.   

Abstract

BACKGROUND/AIMS: Mutations in the amyloid precursor protein gene were the first to be recognized as a cause of Alzheimer's disease (AD).
METHODS: We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val717Ile), known as London mutation.
RESULTS: In 1 family, this mutation was responsible for AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so far. Two subjects of the other family with AD diagnosis were carriers of the same mutation.
CONCLUSION: All AD subjects showed a cognitive profile characterized by early impairment in long-term memory, shifting abilities and affective symptoms beginning in the fifth decade of life. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523046     DOI: 10.1159/000313541

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  5 in total

1.  Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.

Authors:  Grace M Lloyd; Jorge A Trejo-Lopez; Yuxing Xia; Karen N McFarland; Sarah J Lincoln; Nilüfer Ertekin-Taner; Benoit I Giasson; Anthony T Yachnis; Stefan Prokop
Journal:  Acta Neuropathol Commun       Date:  2020-03-12       Impact factor: 7.801

Review 2.  Τhe Greek Variant in APP Gene: The Phenotypic Spectrum of APP Mutations.

Authors:  Stefania Kalampokini; Despoina Georgouli; Eleni Patrikiou; Antonios Provatas; Varvara Valotassiou; Panagiotis Georgoulias; Cleanthe Spanaki; Georgios M Hadjigeorgiou; Georgia Xiromerisiou
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

3.  Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivo model of Alzheimer's disease.

Authors:  Tina Löffler; Stefanie Flunkert; Daniel Havas; Cornelia Schweinzer; Marni Uger; Manfred Windisch; Ernst Steyrer; Birgit Hutter-Paier
Journal:  J Neuroinflammation       Date:  2014-05-01       Impact factor: 8.322

4.  Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network.

Authors:  Celeste M Karch; Damián Hernández; Jen-Chyong Wang; Jacob Marsh; Alex W Hewitt; Simon Hsu; Joanne Norton; Denise Levitch; Tamara Donahue; Wendy Sigurdson; Bernardino Ghetti; Martin Farlow; Jasmeer Chhatwal; Sarah Berman; Carlos Cruchaga; John C Morris; Randall J Bateman; Alice Pébay; Alison M Goate
Journal:  Alzheimers Res Ther       Date:  2018-07-25       Impact factor: 6.982

Review 5.  Gene mutations associated with early onset familial Alzheimer's disease in China: An overview and current status.

Authors:  Qi Qin; Yunsi Yin; Yan Wang; Yuanyuan Lu; Yi Tang; Jianping Jia
Journal:  Mol Genet Genomic Med       Date:  2020-08-06       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.